Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 7/20 | 0.41 |
| ▸ | HSP90AB1 | P08238 | 7/20 | 0.41 |
| ▸ | IDO1 | P14902 | 2/20 | 0.34 |
| ▸ | TDO2 | P48775 | 2/20 | 0.34 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.34 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.34 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.33 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.33 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.33 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.32 |
| ▸ | NOS1 | P29475 | 2/20 | 0.32 |
| ▸ | ALOX15B | O15296 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19953065 | 0.73 | TDO2 (0.46) | HSP90AA1HSP90AB1IDO1TDO2CYP11B1 | |
| SCHEMBL28531423 | 0.73 | HSP90AA1 (0.50) | HSP90AA1HSP90AB1IDO1CYP2C9PTGER1 | |
| SCHEMBL10235433 | 0.65 | NOS1 (0.49) | HSP90AA1HSP90AB1IDO1TDO2CYP11B1 | |
| SCHEMBL12653304 | 0.65 | TP53 (0.46) | IDO1CYP1A2L3MBTL1LMNATP53 | |
| SCHEMBL12676747 | 0.65 | CYP11B1 (0.50) | HSP90AA1HSP90AB1IDO1CYP11B1CYP11B2 | |
| SCHEMBL19953079 | 0.64 | HSP90AA1 (0.48) | HSP90AA1HSP90AB1IDO1MAPT | |
| SCHEMBL1075925 | 0.63 | HSP90AA1 (0.47) | HSP90AA1HSP90AB1CYP11B1CYP11B2 | |
| SCHEMBL19953061 | 0.63 | HSP90AA1 (0.51) | HSP90AA1HSP90AB1IDO1CYP11B1CYP11B2 | |
| SCHEMBL27831303 | 0.62 | CYP11B1 (0.45) | HSP90AA1HSP90AB1IDO1CYP11B1CYP11B2 | |
| SCHEMBL28534427 | 0.62 | MAPT (0.50) | HSP90AA1HSP90AB1CYP2C9MAPK14CRBN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2287141-B1 | METHOD FOR PRODUCING UNSATURATED ORGANIC COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2015-10-21 | — | — | EP | disclosed |
| CN-102015585-B | Method for producing unsaturated organic compound | SUMITOMO CHEMICAL CO | 2013-06-19 | — | — | CN | disclosed |
| US-8237002-B2 | Method for producing unsaturated organic compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-08-07 | — | — | US | disclosed |
| CN-102015585-A | Method for producing unsaturated organic compound | SUMITOMO CHEMICAL CO | 2011-04-13 | — | — | CN | disclosed |
| US-20110046380-A1 | METHOD FOR PRODUCING UNSATURATED ORGANIC COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-02-24 | — | — | US | disclosed |
| EP-2287141-A1 | METHOD FOR PRODUCING UNSATURATED ORGANIC COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2011-02-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110046380-A1 | METHOD FOR PRODUCING UNSATURATED ORGANIC COMPOUND | NIT2, NOS1, CHRM1 | HSP90AA1 3732/4885HSP90AB1 3711/4885IDO1 253/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.